Table 5 Cost parameters
Parameter | Value (€) | Comment |
|---|---|---|
Preventicus screening | ||
Preventicus app | 47.54 | |
Assessment and diagnosis | 297.50 | |
Outpatient treatment | Source: EBM catalogue [67] | |
GP consultation, age below 76 | 16.73 | EBM catalogue no. 0300 |
GP consultation, age 76 or above | 22.37 | |
INR coagulation measurement | 0.75 | EBM catalogue no. 32110 |
Medication: VKA | 0.20 | Yearly costs: 73 € |
Medication: NOAC | 3.00 | Yearly costs: 1095 € |
NOAC prices after patent expiration (% of current prices) | 55% | Reduced yearly costs: 602 € |
Medication: rebate granted | 10% | Assumption |
Strokes / ICH | ||
Stroke costs, year 1 | 21.060 | 2018 costs, inflated data based on |
Stroke costs, follow-up years | 6.211 | Kolominsky-Rabas [3] |
Inflation factor 2006–2018 | 113.7% | Statistisches Bundesamt |
ICH, percentage of stroke costs | 150% | Assumption |
Bleeding | ||
Minor bleeding | 50 | cost assumption by [44] |
Major bleeing | 2.050 | DRG catalogue numbers G70A-C and G46B) |
Risk structure compensation | Source: 2018 HMG catalogue values | |
HMG 092 (Arrhythmias) | 1.249 | |
HMG 092 decrease after NOAC patent expiration | 90% | per year. Assumption: compensation will bedecreased because of lower medication costs until a minimum of 700€ is reached. |
HMG 096 (Ischaemic strokes) | 2.248 | |
HMG 095 (ICH) | 5.831 | |